Senegals Political Turmoil Deepens as President Dissolves Government Amid Debt Crisis Zydus Lifesciences Revises Buyback Terms Price Hiked to Rs 1260 Share Count Reduced Indonesia Targets Major Palm Oil Producers Over Alleged UnderInvoicing Australia Urged to Simplify Regulatory Framework to Boost Capital Inflows Outgoing Watchdog Says Veteran Trader Steve Burns Warns of Potential 50 Decline Amid Ignored Bear Market Signal Spotify Shares Jump 13 on AI Partnership with UMG and Upbeat Guidance Ramaco Resources METC Q1 2026 Earnings EPS Misses Estimates by 4045 While Stock Gains nVent Electric plc NVT Q1 2026 Earnings EPS Beats Estimates by 1475 AVXL Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued RD Focus RILY Q1 2024 Earnings Loss Per Share of 171 Amid Strategic Adjustments Ethos Technologies LIFE Q1 2026 Earnings Stellar EPS Surprise Fails to Lift Stock as Revenue Details Remain Elusive WAVE Q1 2026 Earnings SmallerThanExpected Loss Drives Positive Surprise Enhabit Inc EHAB Edges Higher Amid Tight Trading Range Surf Air Mobility SRFM Shows Modest Recovery Testing Key Resistance at 130 Waystar Holding Corp WAY Rallies 39 as Momentum Builds Toward Key Resistance Tyra Biosciences Inc TYRA Faces Modest Decline as Shares Test Key Support Zone Legend Biotech LEGN Surges Nearly 5 as Biotech Sector Momentum Builds Phillips Connect Appoints Mark Wallin as President and General Manager Jefferson Capital Inc JCAP Q1 2026 Earnings EPS Beats Estimates but Stock Slides on Mixed Signals ARM Holdings Surges 48 as Semiconductor Demand Drives Momentum SCCF Q4 2025 Earnings Massive EPS Surprise of 782 Driven by Strong Operational Performance PRIM Q1 2026 Earnings EPS Misses Estimate by 315 Stock Still Climbs 69 LFT Q1 2026 Earnings EPS Miss Weighs on Market Sentiment AIG Q1 2026 Earnings Strong EPS Surprise Amidst Steady Operational Execution HAFN Q4 2025 Earnings EPS Misses Estimates as Shares Slide 34 AAON Q1 2026 Earnings Stellar EPS Beat Highlights Strong Execution Despite Stock Dip Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress